↓ Skip to main content

Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer

Overview of attention for article published in Frontiers in Pharmacology, January 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
twitter
15 X users
peer_reviews
1 peer review site
facebook
25 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer
Published in
Frontiers in Pharmacology, January 2013
DOI 10.3389/fphar.2013.00080
Pubmed ID
Authors

Gongbo Li, Stacey Thomas, Jeremy J. Johnson

Abstract

The mangosteen (Garcinia mangostana) is a tropical fruit native to Southeast Asia and has long been reported to contain multiple health promoting properties. This fruit is an abundant source of xanthones, a class of polyphenolic compounds with a distinctive tricyclic aromatic ring system and is largely responsible for its biological activities including anti-cancer activity. Herein we describe the anti-cancer activity and mechanisms of mangosteen polyphenolic xanthones including α-Mangostin against breast cancer and prostate cancer. So far, extracts and individual xanthones have been found to induce apoptosis and inhibit proliferation on cancer cells in vitro and in vivo. Based on the reported findings there is clear evidence that these polyphenols target multiple signaling pathways involved in cell cycle modulation and apoptosis. Further work is required to understand its potential for health promotion and potential drug discovery for prostate and breast cancer chemoprevention.

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 150 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 16%
Student > Bachelor 24 16%
Student > Ph. D. Student 12 8%
Researcher 11 7%
Student > Doctoral Student 7 5%
Other 16 11%
Unknown 56 37%
Readers by discipline Count As %
Medicine and Dentistry 18 12%
Pharmacology, Toxicology and Pharmaceutical Science 16 11%
Agricultural and Biological Sciences 14 9%
Biochemistry, Genetics and Molecular Biology 14 9%
Chemistry 14 9%
Other 16 11%
Unknown 58 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2017.
All research outputs
#1,113,915
of 22,711,645 outputs
Outputs from Frontiers in Pharmacology
#361
of 15,939 outputs
Outputs of similar age
#10,298
of 280,737 outputs
Outputs of similar age from Frontiers in Pharmacology
#6
of 167 outputs
Altmetric has tracked 22,711,645 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,939 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,737 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.